Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02991365 : Effect of Weight Loss on Brain Insulin Sensitivity in Humans
PhaseN/A
AgesMin: 40 Years Max: 75 Years
Eligibility
Inclusion Criteria:

- HbA1c <6.5%

- Age between 40 and 75 years

- No intake of antidiabetic drugs or drugs for weight reduction

- no steroid intake

- Stable medication over 10 weeks before the start of the study

Exclusion Criteria:

- Persons who wear non-removable metal parts in or on the body.

- Persons with reduced temperature sensitivity and / or increased sensitivity to
heating of the body

- Cardiovascular disease can not be ruled out, e.g. manifest coronary heart disease,
heart failure greater than NYHA 2, previous heart attack, stroke condition

- Persons with hearing impairment or increased sensitivity to loud noises

- People with claustrophobia

- Minors or non-consenting subjects are also excluded

- Subjects with an operation less than 3 months

- Simultaneous participation in other studies

- Neurological and psychiatric disorders

- Subjects with hemoglobin Hb <11 g / dl

- Hypersensitivity to any of the substances used
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT02991365      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740